全文获取类型
收费全文 | 31853篇 |
免费 | 1806篇 |
国内免费 | 99篇 |
专业分类
耳鼻咽喉 | 252篇 |
儿科学 | 1092篇 |
妇产科学 | 916篇 |
基础医学 | 3569篇 |
口腔科学 | 390篇 |
临床医学 | 5819篇 |
内科学 | 5317篇 |
皮肤病学 | 343篇 |
神经病学 | 3111篇 |
特种医学 | 630篇 |
外国民族医学 | 1篇 |
外科学 | 3056篇 |
综合类 | 297篇 |
现状与发展 | 1篇 |
一般理论 | 50篇 |
预防医学 | 4457篇 |
眼科学 | 444篇 |
药学 | 1847篇 |
中国医学 | 33篇 |
肿瘤学 | 2133篇 |
出版年
2023年 | 192篇 |
2022年 | 326篇 |
2021年 | 591篇 |
2020年 | 424篇 |
2019年 | 651篇 |
2018年 | 807篇 |
2017年 | 562篇 |
2016年 | 633篇 |
2015年 | 672篇 |
2014年 | 990篇 |
2013年 | 1589篇 |
2012年 | 2295篇 |
2011年 | 2424篇 |
2010年 | 1286篇 |
2009年 | 1127篇 |
2008年 | 2189篇 |
2007年 | 2386篇 |
2006年 | 2272篇 |
2005年 | 2204篇 |
2004年 | 2037篇 |
2003年 | 1959篇 |
2002年 | 1868篇 |
2001年 | 218篇 |
2000年 | 180篇 |
1999年 | 280篇 |
1998年 | 372篇 |
1997年 | 311篇 |
1996年 | 245篇 |
1995年 | 274篇 |
1994年 | 213篇 |
1993年 | 210篇 |
1992年 | 131篇 |
1991年 | 136篇 |
1990年 | 135篇 |
1989年 | 111篇 |
1988年 | 102篇 |
1987年 | 94篇 |
1986年 | 92篇 |
1985年 | 103篇 |
1984年 | 124篇 |
1983年 | 126篇 |
1982年 | 144篇 |
1981年 | 139篇 |
1980年 | 118篇 |
1979年 | 56篇 |
1978年 | 71篇 |
1977年 | 61篇 |
1976年 | 47篇 |
1975年 | 36篇 |
1974年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
Jacobo E. Mintzer M.D. Mark P. Rubert Ph.D. David Loewenstein Ph.D. Edgardo Gamez M.D. Agustin Millor L.C.S.W. Rocio Quinteros M.S. Linda Flores M.D. Meridith Miller R.N. Ph.D. Adrianne Rainerman Carl Eisdorfer Ph.D. M.D. 《Community mental health journal》1992,28(4):293-303
This study assessed Cuban-American Hispanic and White non-Hispanic daughters who were major caregivers for their mothers suffering from Alzheimer's Disease. Although patients in both ethnic groups did not differ in their level of cognitive and functional impairment, Cuban-American Hispanic patients were significantly more likely to be living in their daughters' homes while the White non-Hispanic patients resided in institutional settings. Caregivers were equivalent in their knowledge and utilization of community services, but Cuban-American daughters were significantly more aware of financial aid resources. Cuban-American patients were significantly more depressed than their White non-Hispanic counterparts with daughters showing similar but nonsignificant trends. The impact of cultural factors on caregiving is discussed. 相似文献
72.
H. A. Tillmann Hein MD C. Tracy Suit MD Linda K. Douning MD Samuel P. Marynick MD J. Michael Putman MD Lily Zhang PhD Michael A.E. Ramsey MD 《Journal of clinical anesthesia》1997,9(8):617
This study retrospectively compares patients who underwent outpatient transvaginal follicle aspiration with either a propofol- or methohexital-based intravenous sedation technique. Data collected from patient charts (n = 212) over a 46-month period were analyzed to determine the effects of each sedation technique on procedure and recovery times, number of retrieved ova, as well as rates of nausea, fertilization, cleavage, pregnancy, and delivery. All patients were included in the study, regardless of age or diagnosis. procedure time was lower in the propofol group (51 t 18 min) than in the methohexital group (61 I 20 min) (p > 0.01). Patients in the methohexital group (139 2 51 min) spent more time in the recovery room than did those in the propofol group (71 ? 34 min) (p > 0.01). The nausea rates were significantly lower in the propofol group compared with the methohexital group (1.9% vs. 14.4%, respectively) (p > 0.02). Fertilization rate in the propofol group was 77.7% and was 62.9% in the methohexital group (p > 0.01). The numbers of retrieved ova and the cleavage rates were similar in both groups. The rate of pregnancy in patients sedated with propofol (46.1%) was higher than the methohexital group (26.9%) (p > 0.02). Delivery rate was 38.5% in the propofol group and 20.6% in the methohexital group (p > 0.02). In summary, propofol intravenous sedation for transvaginal follicle aspiration was associ- ated with an improved outcome. Pregnancy and delivery rates were higher while nausea, an unpleasant side effect, was sharply reduced. 相似文献
73.
74.
75.
76.
77.
78.
Acquired immunodeficiency syndrome (AIDS) is a serious disease that has special concern for the health care provider. AIDS has continued to grow despite control efforts. As the disease infectivity period remains lengthy, and the heterosexual population is affected to a greater degree, the level of anxiety has also risen despite educational endeavours. Many fears and anxieties have been associated with AIDS patients by health care workers. The reduction of stress, perceived risk and discomfort following educational efforts have been supported in past research. Educational programmes will need to be given for current health care workers at all levels as well as nursing students. Future nurses must be prepared to meet this challenge. This study was conducted using a convenience sample of nursing students at a university in western United States. Its purpose was to assess any changes that occurred in state anxiety following an educational presentation. Spielberge's State-Trait Anxiety Inventory was used as the measurement instrument. Some anxiety levels were significantly reduced. 相似文献
79.
80.
Allen Cato III Linda E. Gustavson Jiang Qian Tawakol El-Shourbagy Edward A. Kelly 《Epilepsia》1998,39(1):43-47
Summary: Purpose: We wished to determine the effect of renal impairment on the pharmacokinetics and tolerability of the new antiepileptic drug tiagabine (TGB).
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献
Methods: We assessed TGB pharmacokinetics and tolerability in 25 subjects with various degrees of renal function (based on creatinine clearance, n = 4–6 per group) from healthy (group I) to requiring hemodialysis (group V) in a single and multiple dose (every 12h), one-period (groups I-IV) or a single dose, two-period (group V) study (4-mg oral doses of TGB · HCl). Blood samples were collected after the first dose (both periods for group V) and after the last dose on day 5 (groups I-IV). TGB plasma concentrations and plasma protein binding were determined by high-performance liquid chromatography (HPLC) and ultrafiltration, respectively.
Results: TGB was well tolerated by all study subjects. The pharmacokinetics of TGB were similar in all subjects; no pharmacokinetic parameter (based on either total or unbound concentrations) was statistically correlated with creatinine clearance. For total TGB in plasma, single-dose mean values of the maximum plasma concentration, clearance, and half-life (t1/2) ranged from 52 to 108 ng/ml, from 7.14 to 11.02 I/h, and from 6.4 to 8.4 h, respectively.
Conclusions: TGB pharmacokinetics and tolerability were independent of renal function; therefore, dosage adjustment is unnecessary for epilepsy patients with renal impairment. 相似文献